González-Pérez LV, Isaza-Guzmán DM, Montaguth-Durán HD, Arango-Pérez EA, Tobón-Arroyave SI. Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population. J Clin Exp Dent. 2020;12(5):e452-60.

doi:10.4317/jced.56647

__________________________________________

References

1. Jyothsna M, Rammanohar M, Kumar K. Histomorphometric analysis of angiogenesis using CD31 immunomarker and mast cell density in oral premalignant and malignant lesions: A pilot study. J Clin Diagn Res. 2017;11:ZC37-40. https://doi.org/10.7860/JCDR/2017/23870.9179 PMid:28274041 PMCid:PMC5324492

2. Wen G, Wang H, Zhong Z. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis. Medicine. 2018;97:e9971. https://doi.org/10.1097/MD.0000000000009971 PMid:29538221 PMCid:PMC5882397

3. Imai FL, Uzawa K, Shiiba M, Watanabe T, Miya T, Kubosawa H, et al. Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncol Rep. 1998;5:1489-91. https://doi.org/10.3892/or.5.6.1489 PMid:9769393

4. Avci H, Ergen A, Bireller ES, Ertugrul B, Cakmakoglu B. A Strong relationship between oral squamous cell carcinoma and DNA repair genes. Biochem Genet. 2017;55:378-86. https://doi.org/10.1007/s10528-017-9806-9 PMid:28639054

5. Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-ad V, Pribitkin E, et al. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 2014;41:217-34. https://doi.org/10.1053/j.seminoncol.2014.03.003 PMid:24787294

6. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002;21:4231-6. https://doi.org/10.1038/sj.onc.1205528 PMid:12082610

7. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011;17:4782-9. https://doi.org/10.1158/1078-0432.CCR-11-0324 PMid:21628494 PMCid:PMC3215270

8. Ovchinnikov DA, Cooper MA, Pandit P, Coman WB, Cooper-White JJ, Keith P, et al. Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl Oncol. 2012;5:321-6. https://doi.org/10.1593/tlo.12232 PMid:23066440 PMCid:PMC3468923

9. Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol. 2014;50:587-92. https://doi.org/10.1016/j.oraloncology.2014.02.015 PMid:24656975

10. Kim HS, Chung WB, Hong SH, Kim JA, Na SY, Jang HJ, et al. Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma. Mol Cells. 2000;10:557-65. https://doi.org/10.1007/s10059-000-0557-8 PMid:11101148

11. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002;62:5295-300. PMid:12234999

12. Kis A, Tatár TZ, Gáll T, Boda R, Tar I, Major T, et al. Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population. Pathol Oncol Res. 2014;20:923-9. https://doi.org/10.1007/s12253-014-9775-9 PMid:24710824

13. Varela-Rey M, Woodhoo A, Martinez-Chantar ML, Mato JM, Lu SC. Alcohol, DNA methylation, and cancer. Alcohol Res. 2013;35:25-35. PMid:2431316

14. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22:4309-18. https://doi.org/10.1128/MCB.22.12.4309-4318.2002 PMid:12024041 PMCid:PMC133879

15. Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res. 2007;13:1179-85. https://doi.org/10.1158/1078-0432.CCR-06-2027 PMid:17317827

16. Malik UU, Zarina S, Pennington SR. Oral squamous cell carcinoma: key clinical questions, biomarker discovery, and the role of proteomics. Arch Oral Biol. 2016;63:53-65. https://doi.org/10.1016/j.archoralbio.2015.11.017 PMid:26691574

17. Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, et al. Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer. 2010;127:2367-73. https://doi.org/10.1002/ijc.25377 PMid:20473870 PMCid:PMC2946507

18. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, et al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics. 2011;6:623-9. https://doi.org/10.4161/epi.6.5.15335 PMid:21739720 PMCid:PMC3230547

19. Mupparapu M, Shanti RM. Evaluation and staging of oral cancer. Dent Clin North Am. 2018;62:47-58. https://doi.org/10.1016/j.cden.2017.08.003 PMid:29126493

20. Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia. 2006;8:46-51. https://doi.org/10.1593/neo.05586 PMid:16533425 PMCid:PMC1584289

21. Ferlazzo N, Currò M, Zinellu A, Caccamo D, Isola G, Ventura V, et al. Influence of MTHFR genetic background on p16 and MGMT methylation in oral squamous cell cancer. Int J Mol Sci. 2017;18:E724. https://doi.org/10.3390/ijms18040724 PMid:28353639 PMCid:PMC5412310

22. Canning M, Guo G, Yu M, Myint C, Groves MW, Byrd JK, et al. Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front Cell Dev Biol. 2019;7:52. https://doi.org/10.3389/fcell.2019.00052 PMid:31024913 PMCid:PMC6465325

23. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148-59. https://doi.org/10.1056/NEJMra072067 PMid:18337604

24. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939-42. PMid:11221887

25. Ji X, Guan C, Jiang X, Li H. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested. Oncotarget. 2016;7:80019-32. https://doi.org/10.18632/oncotarget.12219 PMid:27683120 PMCid:PMC5346768

26. Lo PH, Xie D, Chan KC, Xu FP, Kuzmin I, Lerman MI, et al. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett. 2007;257:199-205. https://doi.org/10.1016/j.canlet.2007.07.018 PMid:17720308

27. Knights AJ, Funnell AP, Crossley M, Pearson RC. Holding tight: cell junctions and cancer spread. Trends Cancer Res. 2012;8:61-9. PMid:23450077

28. Lim Y, Wan Y, Vagenas D, Ovchinnikov DA, Perry CF, Davis MJ, et al. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC Cancer. 2016;16:749. https://doi.org/10.1186/s12885-016-2785-0 PMid:27663357 PMCid:PMC5034533

29. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010; 20:440-6. https://doi.org/10.1101/gr.103606.109 PMid:20219944 PMCid:PMC2847747

30. Johansson A, Enroth S, Gyllensten U. Continuous aging of the human DNA methylome throughout the human lifespan. PLoS One. 2013;8:e67378. https://doi.org/10.1371/journal.pone.0067378 PMid:23826282 PMCid:PMC3695075